Summary
The hypoglycemic action of an antihistaminic drug—Antazoline hydrochloride—is demonstrated. It is shown that this action is rather moderate. Its mechanism and therapeutic value are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jauregui, Hernandez R.: Rev. Med. y Cienees Afines (Mexico) 9:111–140, 1950; 10:127–143, 1951.
Dreux, O.: Arch. Brazil Med. 40:253–258, 1950.
Graf, W. and Nilzen, O.: Act. dermat. venereal, 28:7–21, 1948.
Genazzini, E., Javicoli, T. and Donatelli, L.: Boll. Soc. ital. biol. sper. 27:787–788, 1951.
Zwang, H. and Jacubeit, M.: Biochem. Ztschr. 323:355–362, 1952.
Jauregui, Hernandez R. and Bautista, Jr. G.: Rev. Med. y Ciencies Afines (Mexico) 8:116–124, 1950.
Nelson, N.: J. Biol. Chem. 153:375–380, 1944.
De Moor, P.,: Le Diabete Alloxanique, Masson, Paris, 1953.
Goldner, M. G. and Jauregui, Hernandez R.: Proc. Soc. Exp. Biol. & Med. 85:347–349, 1954.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goldner, M.G., Jauregui, R.H. Hypoglycemic action of an antihistaminic a clinical evaluation. Amer. Jour. Dig. Dis. 21, 160–163 (1954). https://doi.org/10.1007/BF02883848
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02883848